Opportunity Information: Apply for RFA HL 19 016
Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (RFA-HL-19-016) is an NIH small business funding opportunity that uses the SBIR Phase I mechanism (R43) and is limited to projects that do not include clinical trials. The overall purpose is to support early-stage research and development of practical technologies that help older adults maintain health and independence while managing or being monitored for heart, lung, blood, and sleep-related conditions. The emphasis is on tools that work in everyday life, provide timely information or support, and fit naturally into home and community settings without being burdensome.
The FOA is specifically looking for design and development efforts for technologies that can monitor health status or deliver care in real time in ways that are accessible, effective, and minimally obtrusive for aging adults. Examples highlighted include novel sensors and monitoring systems, home-use point-of-care devices, home- or mobile-based therapy and rehabilitation tools, and information systems that support care. In practice, that could mean better at-home physiological monitoring, easier-to-use devices that capture clinically meaningful measurements outside of a clinic, or digital systems that help users and caregivers interpret trends and respond early when something begins to change. A central theme is that improved technology design can enable earlier and more accurate detection of changes that might threaten an older adult’s ability to live independently.
A major requirement running through the announcement is human-centered design with serious attention to usability for populations that often get left behind by mainstream technology. Applicants are expected to incorporate human factors engineering from the start, not as a late-stage add-on. The FOA calls out the needs of people with disabilities, individuals aging with mild impairments, and people living with chronic conditions. Usability considerations specifically mentioned include patient-facing display design, accommodations for hearing and vision impairments, tactile or dexterity limitations, and literacy (including health literacy). The expectation is that the proposed technology will be designed so that real-world users can actually operate it correctly and consistently, which directly affects data quality, safety, adherence, and ultimately the usefulness of the technology for independent living.
From an administrative standpoint, the opportunity is categorized as a discretionary grant under NIH, and the eligible applicant pool is limited to small businesses, consistent with the SBIR Phase I (R43) mechanism. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible, although foreign components as defined by NIH policy may be allowable in some cases (the FOA directs applicants to NIH Grants Policy definitions and the opportunity details for the exact boundaries). The participating agency is the National Institutes of Health, and the opportunity references CFDA numbers 93.233, 93.837, 93.838, 93.839, and 93.840, which align with NIH programs relevant to heart, lung, blood, and sleep research areas.
Key identifying details include the Funding Opportunity Number RFA-HL-19-016, with the original posting date reflected by a creation date of March 15, 2018, and an original closing date of June 10, 2020. While the source text does not provide an award ceiling or expected number of awards, the core takeaway is that this FOA is meant to stimulate Phase I R&D by small businesses to create usable, home-appropriate, and minimally intrusive health technologies tailored to older adults and people with functional limitations, with the end goal of supporting healthier, safer independent living in conditions affecting the heart, lungs, blood, and sleep.Apply for RFA HL 19 016
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.837, 93.838, 93.839, 93.840.
- This funding opportunity was created on 2018-03-15.
- Applicants must submit their applications by 2020-06-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name and number of this funding opportunity?
The opportunity is titled Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders and the Funding Opportunity Number is RFA-HL-19-016.
Which federal agency is offering this opportunity?
The participating agency is the National Institutes of Health (NIH).
What type of grant is this?
This is an NIH discretionary grant funding opportunity using the SBIR Phase I mechanism, specifically R43.
Who is eligible to apply?
Eligibility is limited to small businesses, consistent with the SBIR Phase I (R43) mechanism.
Are clinical trials allowed under this FOA?
No. This opportunity is limited to projects that do not include clinical trials.
What is the overall purpose of RFA-HL-19-016?
The purpose is to support early-stage research and development of practical technologies that help older adults maintain health and independence while managing or being monitored for heart, lung, blood, and sleep-related conditions.
What kinds of technologies does the FOA emphasize?
The FOA emphasizes technologies that work in everyday life, provide timely information or support, and fit naturally into home and community settings without being burdensome or disruptive.
What is meant by “real-time” monitoring or care in this announcement?
The FOA highlights design and development efforts for technologies that can monitor health status or deliver care in real time in ways that are accessible, effective, and minimally obtrusive for aging adults.
What are example project areas mentioned in the FOA?
Examples include novel sensors and monitoring systems, home-use point-of-care devices, home- or mobile-based therapy and rehabilitation tools, and information systems that support care.
Does the FOA focus on technologies used in clinics or at home?
The emphasis is on technologies that can be used in home and community settings, including tools that enable clinically meaningful measurements outside of a clinic.
What problem is the FOA trying to solve for older adults?
A central theme is enabling earlier and more accurate detection of changes that could threaten an older adult’s ability to live independently, using better-designed technology that is practical in everyday life.
Why is usability such a major requirement?
The FOA stresses that technology must be designed so real-world users can operate it correctly and consistently, because usability directly affects data quality, safety, adherence, and overall usefulness for independent living.
Is human-centered design expected, and when should it be incorporated?
Yes. Applicants are expected to incorporate human-centered design and human factors engineering from the start, not as a late-stage add-on.
Which user populations does the FOA call out for special usability attention?
The FOA specifically calls out people with disabilities, individuals aging with mild impairments, and people living with chronic conditions.
What usability considerations are specifically mentioned?
Usability considerations mentioned include patient-facing display design, accommodations for hearing and vision impairments, support for tactile or dexterity limitations, and addressing literacy (including health literacy).
What does “minimally obtrusive” mean in the context of this FOA?
It means the technology should fit naturally into daily routines in the home or community and should not be overly burdensome to use, wear, maintain, or interpret.
Is the FOA interested in tools that help caregivers and users interpret data trends?
Yes. The FOA describes digital or information systems that help users and caregivers interpret trends and respond early when something begins to change.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply.
Can a U.S. organization include non-U.S. components?
No. Non-U.S. components of U.S. organizations are also not eligible.
Are any foreign components allowed at all?
The FOA notes that foreign components (as defined by NIH policy) may be allowable in some cases and directs applicants to NIH Grants Policy definitions and the opportunity details for the exact boundaries.
Which research areas does this FOA align with?
The FOA targets technologies related to conditions affecting the heart, lungs, blood, and sleep, with an emphasis on supporting healthy independent living for older adults.
What CFDA numbers are referenced for this opportunity?
The opportunity references CFDA numbers 93.233, 93.837, 93.838, 93.839, and 93.840.
What are the key dates provided in the source information?
The original posting date is reflected by a creation date of March 15, 2018, and the original closing date is June 10, 2020.
Does the provided information include an award ceiling or the expected number of awards?
No. The source information does not provide an award ceiling or an expected number of awards.
What stage of development is this FOA intended to support?
It is intended to stimulate Phase I small business R&D efforts to create usable, home-appropriate, minimally intrusive health technologies tailored to older adults and people with functional limitations.
Browse more opportunities from the same category: Health
Next opportunity: “Television Content Fund” program
Previous opportunity: Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 19 016
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 19 016) also looked into and applied for these:
| Funding Opportunity |
|---|
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22) - Clinical Trial Required Apply for PAR 18 710 Funding Number: PAR 18 710 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) Apply for PAR 18 711 Funding Number: PAR 18 711 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R41/R42)-Clinical Trial Not Allowed Apply for PA 18 709 Funding Number: PA 18 709 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) Apply for RFA AI 18 004 Funding Number: RFA AI 18 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) Apply for PAR 18 712 Funding Number: PAR 18 712 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 708 Funding Number: PA 18 708 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed) Apply for RFA AI 18 005 Funding Number: RFA AI 18 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Request for Information: USAID/DRC’s WASH Planning Apply for 72066018RFI01 Funding Number: 72066018RFI01 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed) Apply for PAR 18 715 Funding Number: PAR 18 715 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Bioethics Research Training Program (D43 Clinical Trial Optional) Apply for PAR 18 716 Funding Number: PAR 18 716 Agency: National Institutes of Health Category: Health Funding Amount: $230,000 |
| Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed) Apply for PA 18 725 Funding Number: PA 18 725 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) Apply for PAR 18 726 Funding Number: PAR 18 726 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed) Apply for PAR 18 721 Funding Number: PAR 18 721 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) Apply for PA 18 724 Funding Number: PA 18 724 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) Apply for PA 18 718 Funding Number: PA 18 718 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) Apply for PA 18 719 Funding Number: PA 18 719 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) Apply for PAR 18 735 Funding Number: PAR 18 735 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional) Apply for PAR 18 736 Funding Number: PAR 18 736 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) Apply for PAR 18 737 Funding Number: PAR 18 737 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 011 Funding Number: RFA RM 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 19 016", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.